Blog Archives

Synthetic Genetics: Beyond DNA and RNA

The Ambiguity of Sexual Fate Determination

Developing a Gene Therapy for Muscular Dystrophy

Gender Re/Evolution: Navigating Developmental, Psychological and Social Facets of Pink and Blue in a Purple World

2017 Symposium Welcome

Larry Gold, Ph.D. is the Founder and Chairman of the board, and past CEO of SomaLogic. Prior to SomaLogic, he founded NeXagen, Inc., which later became NeXstar Pharmaceuticals, Inc. In 1999, NeXstar merged with Gilead Sciences, Inc. to form a global organization committed to the discovery, development and commercialization of novel products that treat infectious diseases. Before forming NeXagen, he also co-founded and served as Co-Director of research at Synergen, Inc., a biotechnology company later acquired by Amgen, Inc.